John Löfblom

32PUBLICATIONS
25CO-AUTHORS
Molecular targetsMedical devicesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyBiocatalysis and enzyme technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 31, 2026
Imaging of ROR1 expression in tumors using radiolabeled affibody molecules.

|Jun 24, 2026
Trimerization of CD40L-specific affibody molecules using collagen domains enhances target binding and CD40 blockade.

|Jun 11, 2026
Combining bacterial display and protein language models to engineer a CD69-binding affibody for molecular imaging of immune activation.

|Apr 16, 2026
Engineering affibody domains as anti-idiotypic masks for nivolumab-based prodrugs.

|Nov 20, 2025
Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents.

Sara S Rinne, Wen Yin, Ruonan Li

|Oct 17, 2024
Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts.

Jie Zhang, Sara S Rinne, Wen Yin

Pageof 6

Frequent Collaborators

18 joint publications

Anna Orlova

14 joint publications

Vladimir Tolmachev

12 joint publications

Anzhelika Vorobyeva

5 joint publications

Cornelia Westerberg